https://sputniknews.in/20260211/russia-ready-to-provide-vaccines-against-melanoma-this-year-10466931.html

Russia Ready to Provide Vaccines Against Melanoma This Year

Sputnik India

Russian scientists from the Gamaleya Center (creators of Sputnik V) announce treatment for the first patients with a new mRNA vaccine for melanoma. 11.02.2026, Sputnik India

2026-02-11T11:18+0530

world news

health

science & tech

russia

https://cdn1.img.sputniknews.in/img/07e8/0c/01/8476549_0:106:2021:1242_1920x0_80_0_0_cfaef263abf7530f89c52af2ab4df358.jpg

Alexander Gintsburg, director of the Gamaleya Center, states preclinical animal trials show >90% efficacy.The Blokhin Cancer Research Centre has received approval for clinical use.Unlike preventive mRNA COVID vaccines, this is a therapeutic cancer vaccine. It's designed to train a patient's immune system to recognize and destroy specific mutations (neoantigens) present on their melanoma cells, offering a personalized treatment approach.

https://sputniknews.in/20260209/national-interest-will-be-guiding-factor-india-on-question-about-russian-oil-10461070.html

russia

Sputnik India

feedback.hindi@sputniknews.com

+74956456601

MIA „Rossiya Segodnya“

252

2026

Sputnik India

feedback.hindi@sputniknews.com

+74956456601

MIA „Rossiya Segodnya“

252

News

en_IN

Sputnik India

feedback.hindi@sputniknews.com

+74956456601

MIA „Rossiya Segodnya“

252

1920

1080

true

1920

1440

true

https://cdn1.img.sputniknews.in/img/07e8/0c/01/8476549_112:0:1907:1346_1920x0_80_0_0_96202623d965e892ed9ad1b12fc0b06d.jpg

1920

true

Sputnik India

feedback.hindi@sputniknews.com

+74956456601

MIA „Rossiya Segodnya“

252

Sputnik India

health, science & tech, russia

Russia Ready to Provide Vaccines Against Melanoma This Year

11:18 11.02.2026

© AP Photo / Matias DelacroixA healthcare worker prepares a dose of the Sputnik V vaccine for COVID-19 as seniors and those considered high risk for contagion are eligible at a vaccination center set up in the parking lot of the Armed Forces Social Prevision Institute (IPSFA) in Caracas, Venezuela, June 7, 2021.

A healthcare worker prepares a dose of the Sputnik V vaccine for COVID-19 as seniors and those considered high risk for contagion are eligible at a vaccination center set up in the parking lot of the Armed Forces Social Prevision Institute (IPSFA) in Caracas, Venezuela, June 7, 2021. - Sputnik India, 1920, 11.02.2026

Russian scientists from the Gamaleya Center (creators of Sputnik V) announce treatment for the first patients with a new mRNA vaccine for melanoma.

Alexander Gintsburg, director of the Gamaleya Center, states preclinical animal trials show >90% efficacy.

The Blokhin Cancer Research Centre has received approval for clinical use.

Unlike preventive mRNA COVID vaccines, this is a therapeutic cancer vaccine. It's designed to train a patient's immune system to recognize and destroy specific mutations (neoantigens) present on their melanoma cells, offering a personalized treatment approach.

Russian pipeline - Sputnik India, 1920, 09.02.2026

Indo-Russian Relations

National Interest Will Be Guiding Factor: India on Question About Russian Oil

9 February, 20:09